Small dose, great effect' cosmetic ingredients inventory
ACI expects healthcare antiseptic manufacturers to lose most active ingredients
The US Food and Drug Administration (FDA) will ban some 80% of active ingredients currently allowed for use in healthcare antiseptics, the American Cleaning Institute (ACI) expects.
Plans to require manufacturers to submit data demonstrating the safety and efficacy of their antibacterial ingredients were set out in a 2015 proposed rule - and are expected to become law when the final rule is issued. The FDA will assess data submitted by industry and decide whether to classify actives as "generally recognised as safe and effective" (Gras/Grae), or ban their use in the products.
ACI expects triclosan to face a ban in healthcare products as well, along with more than 20 other ingredients, its associate vice president for environmental safety, Paul DeLeo, told CW+BiocidesHub.
Some substances will be banned due to a lack of support by industry, he said. "Companies know it won't get FDA approval so they are not willing to do the additional testing the agency is requiring."
Others will fail because the data to support them is too challenging to generate. The agency, he says, is asking for "new methods that we are not aware of anyone having successfully completed in this space", but it has been willing to give companies more time.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-07-06
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Syngenta's nicotinamide insecticide Flumetnicam received provisional ISO generic name approval
-
FDA Breakthrough Therapy Designation for Topical Vitamin A Derivatives to Treat Inherited Skin Diseases
-
Terminal Purchase Enthusiasm Is Average, Only A Small Amount of Just Need to Purchase Mainly
-
Xinhecheng: An accident at the Shangyu base has no impact on production
-
Givaudan Breaks Ground on New Fragrance Factory in Guangzhou
-
Elkem Launches Innovative Formulations with Low-Cyclic Silicone Ingredients
-
HARKE GROUP Acquires Vendico Group, Strengthening Nordic Market leadership
-
DKSH to Distribute Point Grey’s Baby and Personal Care Portfolio in Vietnam
-
KKR Acquires Korea’s Samhwa in $528 Million Deal
-
Puig Reports €2.3 Billion Sales in H1 2025, with Asia Pacific and Beauty Leading Growth
Recommend Reading
-
Unilever Invests 30 Billion Forints in New Deodorant Plant in Hungary
-
End of an Era: KDC/One to Close 150-Year-Old Somerset Cosmetics Factory as Production Shifts to Scotland
-
Toray to Transfer Stake in Soda Aromatic to Samyang
-
L'Oréal to Invest $80 Million in Mexico Factory Expansion
-
Retinol in Cosmetics: Regulatory Tightening and Market Changes
-
Methanol Market Prices Fluctuate Narrowly
-
Formic Acid Shows Moving Average Crossover, Upward Momentum Limited
-
China Suspends Sulfuric Acid Exports, Global Copper and Fertilizer Supply Under Strain
-
“Milk Sugar 2.0” Cleared for Takeoff: EU Greenlights Next-Gen Human-Identical Oligosaccharide for Infant Nutrition
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28